Interventions aimed at decreasing obesity in children younger than 2 years: a systematic review

Philip J Ciampa1, Disha Kumar, Shari L Barkin

  • 1Program in Effective Health Communication, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-8300, USA.

Insights

Preventing childhood obesity in infants is challenging. Interventions show limited success in improving weight status but may enhance nutrition knowledge and dietary habits in children under two.

Area of Science:

  • Pediatrics
  • Public Health
  • Nutrition Science

Background:

  • Childhood overweight and obesity are significant public health concerns.
  • Early intervention is crucial for long-term health outcomes.
  • Limited research exists on interventions for children under two years old.

Purpose of the Study:

  • To evaluate the effectiveness of interventions aimed at preventing or reducing overweight and obesity in children younger than two years.
  • To synthesize existing evidence on interventions targeting infant weight status and related factors.

Main Methods:

  • A systematic review of published studies was conducted.
  • Databases searched included MEDLINE, Cochrane, CINAHL, and Web of Science.
  • Studies were assessed for quality, with outcomes including weight status, diet, physical activity, and parental knowledge.

Main Results:

  • Ten studies met inclusion criteria, primarily using educational interventions for nutrition and physical activity.
  • Interventions showed modest success in improving dietary intake and parental knowledge but did not impact child weight status.
  • Included studies were generally of poor to fair quality.

Conclusions:

  • Evidence for interventions to prevent or reduce obesity in children under two is limited.
  • Future research should focus on rigorous, family-centered interventions for sustainable impact.
  • Targeting early dietary intake and parental knowledge shows potential.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...